Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11118058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.

  2000cited by this paper
• Regulation of angiogenesis via vascular endothelial growth factor receptors.

  2000cited by this paper
• Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance*

  1999cited by this paper
• Antiangiogenic activity of the cleaved conformation of the serpin antithrombin.

  1999cited by this paper
• Formation of the antithrombin heterodimer in vivo and the onset of thrombosis.

  1999cited by this paper
• Fibronectin and its integrin receptors in cancer.

  1999cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cited by this paper
• Focal adhesion kinase in integrin-mediated signaling.

  1999cited by this paper
• Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma.

  1999cited by this paper
• Integrin-mediated Signals Regulated by Members of the Rho Family of GTPases

  1998cited by this paper
• Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

  1998cited by this paper
• Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• Antithrombin. A bloody important serpin.

  1997cited by this paper
• Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and -Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related Protein (*)

  1996cited by this paper
• Probing serpin reactive-loop conformations by proteolytic cleavage.

  1996cited by this paper
• Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice

  1995cited by this paper
• Definition of Two Angiogenic Pathways by Distinct αv Integrins

  1995cited by this paper
• Definition of two angiogenic pathways by distinct alpha v integrins.

  1995cited by this paper
• Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Regulation of Thrombin Activity by Antithrombin and Heparin

  1994cited by this paper
• Biological implications of a 3 A structure of dimeric antithrombin.

  1994cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

  1994cited by this paper
• Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

  1994cited by this paper
• Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.

  1993cited by this paper
• Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

  1993cited by this paper
• The platelet-derived growth factor beta-receptor kinase insert confers specific signaling properties to a chimeric fibroblast growth factor receptor.

  1992cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells.

  1991cited by this paper
• Assays for angiogenesis: a review.

  1991cited by this paper
• Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor.

  1988cited by this paper
• Enhanced chemiluminescent method for the detection of DNA dot-hybridization assays.

  1985cited by this paper
• Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth.

  1985cited by this paper
• Production in vitro and properties of a modified form of bovine antithrombin, cleaved at the active site by thrombin.

  1982cited by this paper
• Cloning and expression of the cDNA for human antithrombin III.

  1982cited by this paper
• Cloning and expression of the cDNA for human antithrom, bin III

  1982cited by this paper
• The production of an inactive form of antithrombin through limited proteolysis by thrombin

  1979cited by this paper

• Real-time imaging of blood coagulation and angiogenesis during development in a zebrafish model of type I antithrombin deficiency

  2025cites this paper
• Assessment of maternal serum SERPINC1, E‐selectin, P‐selectin, and RBP4 levels in pregnancies with early‐ and late‐onset preeclampsia

  2023cites this paper
• Early Prediction Model of Gestational Hypertension by Multi-Biomarkers Before 20 Weeks Gestation

  2021cites this paper
• Structural alteration in hypochlorous acid modified antithrombin indicates generation of neo-epitopes.

  2020cites this paper
• PKC (Protein Kinase C)-δ Modulates AT (Antithrombin) Signaling in Vascular Endothelial Cells

  2020cites this paper
• Antithrombin: An anticoagulant, anti‐inflammatory and antibacterial serpin

  2020cites this paper
• Identification of a novel alternatively spliced isoform of antithrombin containing an additional RCL-like loop.

  2019cites this paper
• Transcriptomic Analysis on Hepatocellular Carcinoma Model in Response to Safranal Treatment

  2018cites this paper
• Targeted therapy of chronic liver diseases with the inhibitors of angiogenesis.

  2018cites this paper
• High levels of latent antithrombin in plasma from patients with antithrombin deficiency

  2017cites this paper
• Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase

  2016cites this paper
• Evaluation d'un variant d'antithrombine dans différentes indications thérapeutiques

  2016cites this paper
• Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.

  2016influential citation
• Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis

  2016cites this paper
• Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.

  2014cites this paper
• Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.

  2013cites this paper
• Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy

  2012cites this paper
• In Vitro and In Vivo Antiangiogenic Properties of the Serpin Protease Nexin-1

  2012cites this paper
• Antithrombin prevents apoptosis by regulating inflammation in the liver in a model of cold ischemia/warm reperfusion injury.

  2012cites this paper
• High Level Expression of Recombinant Human Antithrombin in the Mammary Gland of Rabbits by Adenoviral Vectors Infection

  2012cites this paper
• Angiogenesis regulation in hormone dependent breast- and ovarian cancer

  2011cites this paper
• Pharmacology and clinical applications of human recombinant antithrombin

  2010cites this paper
• Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung.

  2009influential citation
• Endogenous inhibitors of angiogenesis: a historical review.

  2009cites this paper
• Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.

  2008cites this paper
• Characterization of the Conformational Alterations, Reduced Anticoagulant Activity, and Enhanced Antiangiogenic Activity of Prelatent Antithrombin*

  2008cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins Kjellberg, Margareta

  2007cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins

  2007cites this paper
• Effects of anticoagulant strategies on activation of inflammation and coagulation

  2007cites this paper
• Antiangiogenic Antithrombin

  2007cites this paper
• Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane

  2007cites this paper
• Antiangiogenic antithrombin.

  2007cites this paper
• An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop‐inserted uncleaved form of antithrombin

  2007cites this paper
• Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase family.

  2007cites this paper
• Update on endogenous inhibitors of angiogenesis.

  2006cites this paper
• Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.

  2006cites this paper
• The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin

  2006cites this paper
• Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow

  2006cites this paper
• Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

  2006cites this paper
• Oxidative mechanism and homeostasis of proteinase/antiproteinase in congestive heart failure.

  2006cites this paper
• Antiangiogenic Antithrombin Blocks the Heparan Sulfate-dependent Binding of Proangiogenic Growth Factors to Their Endothelial Cell Receptors

  2006cites this paper
• Targeting angiogenesis for the treatment of sarcoma

  2006cites this paper
• The heparin-binding site of antithrombin is crucial for antiangiogenic activity.

  2005cites this paper
• Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis‐dependent tumor growth and peritoneal dissemination

  2005cites this paper
• Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

  2005cites this paper
• Angiogenesis inhibitors found within the haemostasis pathway

  2005cites this paper
• Effect of antithrombin III on neutrophil deformability

  2005cites this paper
• T HE H EPARIN B INDING S ITE OF A NTITHROMBIN I S C RUCIAL FOR A NTIANGIOGENIC A CTIVITY

  2005cites this paper
• Interfering with Hemostatic System Components: Possible New Approaches to Antiangiogenic Therapy

  2004influential citation
• Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases.

  2004cites this paper
• Contribution of the Hemostatic System to Angiogenesis in Cancer

  2004cites this paper
• Latent antithrombin does not affect physiological angiogenesis: an in vivo study on vascularization of grafted ovarian follicles.

  2004cites this paper
• Latent antithrombin and its detection, formation and turnover in the circulation

  2004cites this paper
• Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.

  2004cites this paper
• Interfering with hemostatic system components: possible new approaches to antiangiogenic therapy.

  2004cites this paper
• Contribution of the hemostatic system to angiogenesis in cancer.

  2004cites this paper
• Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

  2003cites this paper
• Inhibition of angiogenesis: A new function for angiotensinogen and des(angiotensin I)angiotensinogen

  2003cites this paper
• Regulation of angiogenesis by the hemostatic system.

  2003cites this paper
• Focal adhesion kinase in cancer.

  2003cites this paper
• Matrix metalloproteinase in left ventricular remodeling and heart failure

  2003cites this paper
• Infection and cancer: the common vein.

  2003cites this paper
• Therapeutic strategies using inhibitors of angiogenesis.

  2003cites this paper
• Latent Antithrombin inhibiert die Angiogenese im A-Mel-3-Fortner Melanom durch verzögerte Ausreifung der neugebildeten Kapillaren

  2003cites this paper
• Probing plasma clearance of the thrombin-antithrombin complex with a monoclonal antibody against the putative serpin-enzyme complex receptor-binding site.

  2003cites this paper
• Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

  2002cites this paper
• The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.

  2002cites this paper
• Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

  2002cites this paper
• Preparative conversion of native human antithrombin to the latent form.

  2002cites this paper
• The Antiangiogenic Agent Neovastat ( Æ-941 ) Induces Endothelial Cell Apoptosis 1

  2002cites this paper
• Antithrombin: a new look at the actions of a serine protease inhibitor

  2002cites this paper
• Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

  2002cites this paper
• Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.

  2002cites this paper
• Generation of multiple angiogenesis inhibitors by human pancreatic cancer.

  2001influential citation
• The Conformational Basis of Thrombosis

  2001cites this paper
• A Novel Anti-angiogenic Form of Antithrombin with Retained Proteinase Binding Ability and Heparin Affinity*

  2001cites this paper